Home › Scleroderma › Maryland
Scleroderma clinical trials in Maryland
6 studies for Scleroderma are looking for participants at sites in Maryland.
Cities in Maryland
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345A Study of AZD0120 in Autoimmune Diseases
- Research Site, Baltimore
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Nov 10, 2026 · NCT07295847A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Nov 2, 2026 · NCT07085104A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07497087A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Baltimore
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- Johns Hopkins University School of Medicine, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.